bohemianwanderer – If you’ve ever undergone a blood test, it’s likely your doctor ordered a complete blood count (CBC). CBC tests are among the most commonly performed medical diagnostics globally, conducted billions of times annually to diagnose conditions and monitor patient health. However, despite their widespread use, the interpretation of CBC results often relies on one-size-fits-all reference intervals that fail to consider individual differences.
As a mathematician at the University of Washington School of Medicine, I focus on leveraging computational tools to enhance clinical blood testing. My team, in collaboration with colleagues at the Higgins Lab at Harvard Medical School, recently analyzed 20 years of blood count data from tens of thousands of patients across the East and West coasts of the United States.
Our newly published research utilized machine learning to establish personalized healthy blood count ranges for individuals. By analyzing historical data, we identified patterns that reflect each patient’s unique health baseline. This approach not only provides a more precise understanding of what constitutes “normal” for each person but also enables early detection of potential health risks.
One of the study’s most significant findings is the ability to predict a patient’s likelihood of developing future diseases based on subtle deviations in their blood test results over time. This predictive capacity could transform how clinicians use routine blood tests, shifting from reactive diagnosis to proactive health management.
Understanding Your CBC Test: Insights Beyond Diagnostics
Many people perceive clinical tests as straightforward diagnostics, such as a COVID-19 or pregnancy test that provides a clear positive or negative result. However, most clinical tests function differently, measuring biological traits that your body continuously adjusts to maintain within a healthy range.
A complete blood count (CBC) test exemplifies this dynamic approach. Instead of a binary result, the CBC creates a detailed profile of your blood cells, including red blood cells, platelets, and white blood cells. This profile serves as a cornerstone for nearly all areas of medical practice, offering insights into various aspects of your health.
For instance, hemoglobin, an iron-containing protein in red blood cells, enables oxygen transportation throughout your body. Low hemoglobin levels may signal iron deficiency, which can lead to fatigue and other symptoms. Monitoring this marker allows healthcare providers to detect and address nutritional or medical issues early.
Platelets, another crucial component measured in a CBC, play a vital role in blood clotting. A low platelet count may indicate internal bleeding, as your body utilizes these cells to form clots and repair injuries. By understanding platelet levels, doctors can diagnose conditions ranging from minor injuries to serious bleeding disorders.
White blood cells, integral to your immune system, respond to infections by increasing in number. A high white cell count often signals that your body is fighting off an infection. This marker can also help doctors identify underlying inflammatory or immune conditions.
Read More : UK Economy Declines for Second Consecutive Month
Personalizing Blood Test Results: Why ‘Normal’ Ranges Might Not Fit Everyone
One of the most common questions about blood tests is, “What defines too high or too low?” Traditionally. Clinicians rely on reference intervals to interpret blood test results. These intervals are established by measuring markers in a group of healthy individuals and identifying the middle 95% as the “normal” range. Any value above or below this range is typically flagged as too high or low.
However, reference intervals have limitations. What is normal for one person may not be normal for another. As individual differences significantly influence blood markers like platelet counts. are influenced by genetics and environmental factors. These personal factors determine what is truly healthy for an individual, often referred to as their “set point.”
For example, while a population-based normal platelet count ranges between 150 and 400 billion cells per liter of blood. Your body might naturally maintain a set point of 200. This means your healthy range could be narrower, such as 150 to 250. Traditional reference intervals may overlook these personalized variations, leading to potential challenges in diagnosis and treatment.
If your set point lies far from a population-based cutoff, doctors might miss diagnosing a condition. Conversely, if your set point is near a cutoff, they could order unnecessary tests, causing undue stress and expense.
Personalized Blood Testing: Using Set Points to Predict and Prevent Future Health Risks
Routine blood tests often provide valuable insights into health, but traditional interpretation methods based on population averages can miss crucial individual variations. Recognizing this, researchers are developing personalized approaches to blood test analysis using machine learning and patient history.
My team studied over 50,000 patients’ blood counts, collected during routine checkups over decades. By analyzing this data, we identified personalized “set points” for various blood markers. These set points reflect the body’s unique regulation of markers such as white blood cells, red blood cells, and platelets.
Our findings revealed that individual normal ranges were about three times narrower than population-based ranges. For instance, while the population’s normal white blood cell count spans 4.0 to 11.0 billion cells per liter, individual ranges were typically tighter, such as 4.5 to 7.0 or 7.5 to 10.0 billion. These personalized ranges offered better insights into health, highlighting anomalies that population-level intervals might overlook.
When we applied personalized set points, they enhanced the diagnosis of conditions like iron deficiency, chronic kidney disease, and hypothyroidism. A test result outside a person’s set point range—even if it fell within the population’s normal range—often signaled potential health issues.
Moreover, set points provided predictive value for future health risks. Patients with elevated white blood cell set points, for instance, faced a higher likelihood of developing Type 2 diabetes. They were also nearly twice as likely to experience mortality from any cause compared to those with lower set points. Other markers similarly predicted disease risks and mortality.
This research underscores the potential of personalized medicine. By leveraging patient history to define health baselines, doctors could refine disease screening, improve early detection, and tailor treatments to individual needs, offering a transformative approach to healthcare.
